Trupanion Inc (NASDAQ:TRUP) has been assigned an average rating of “Buy” from the thirteen brokerages that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $44.33.
Several brokerages recently issued reports on TRUP. Zacks Investment Research upgraded shares of Trupanion from a “sell” rating to a “hold” rating in a research report on Thursday, May 16th. BidaskClub upgraded shares of Trupanion from a “buy” rating to a “strong-buy” rating in a research report on Monday, April 1st. Guggenheim began coverage on shares of Trupanion in a research report on Thursday, May 23rd. They set a “buy” rating and a $35.00 price target on the stock. Finally, ValuEngine upgraded shares of Trupanion from a “hold” rating to a “buy” rating in a research report on Thursday, March 21st.
In other Trupanion news, CEO Darryl Rawlings sold 4,000 shares of the company’s stock in a transaction dated Tuesday, April 16th. The shares were sold at an average price of $35.04, for a total transaction of $140,160.00. Following the transaction, the chief executive officer now directly owns 1,538,380 shares in the company, valued at approximately $53,904,835.20. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Dan Levitan sold 15,000 shares of the company’s stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $29.56, for a total transaction of $443,400.00. Following the transaction, the director now owns 73,487 shares in the company, valued at $2,172,275.72. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 82,903 shares of company stock worth $2,653,728. Corporate insiders own 13.61% of the company’s stock.
NASDAQ TRUP traded up $0.15 on Monday, hitting $34.29. 24,866 shares of the company were exchanged, compared to its average volume of 214,787. The company has a market cap of $1.18 billion, a price-to-earnings ratio of -1,143.00 and a beta of 1.21. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.14. Trupanion has a 1-year low of $22.38 and a 1-year high of $46.70.
Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Thursday, May 2nd. The financial services provider reported ($0.04) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.01) by ($0.03). The company had revenue of $86.98 million for the quarter, compared to analyst estimates of $85.87 million. Trupanion had a negative return on equity of 0.59% and a negative net margin of 0.23%. The firm’s quarterly revenue was up 24.7% on a year-over-year basis. During the same quarter last year, the company earned ($0.05) EPS. On average, equities analysts expect that Trupanion will post -0.08 earnings per share for the current year.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Read More: Hedge Funds
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.